
The first part of our conversation with Christopher Stanley, M.D., MBA, the newest member of the Managed Healthcare Executive editorial advisory board.
Letrozole therapy, in follow-up to 5 years of tamoxifen treatment, significantly improves disease-free survival compared to placebo, according to a study published in The New England Journal of Medicine.






